DOQCS database

NCBS Home page

Accession List

Pathway List

Authorized Users

Help

News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.

Molecule List for Accession fig3_CaMKII (Accession Number2)

Default ordering is done according to Pathway Number. Table headers can be used for changing the default ordering.

arrow indicates that ordering is done according to ascending or descending order.
The entries are grouped according to Pathway Number and are alternately color coded using

and

color.

	Name	Pathway Name / Pathway No.	Accession Type	Initial Conc. (uM)	Volume (fL)	Buffered	Sum Total Of
1	CaMKII	CaMKII Pathway No. 13	Network	70	1000	No	-
2	CaMKII-CaM	CaMKII Pathway No. 13	Network	0	1000	No	-
3	CaMKII-thr286*-C aM	CaMKII Pathway No. 13	Network	0	1000	No	-
4	CaMKII***	CaMKII Pathway No. 13	Network	0	1000	No	-
5	CaMKII-thr286	CaMKII Pathway No. 13	Network	0	1000	No	-
6	CaMK-thr306	CaMKII Pathway No. 13	Network	0	1000	No	-
7	CaM-Ca4	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	0	1000	No	-
8	PP1-active	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	1.8	1000	No	-
9	CaM	CaM Pathway No. 14	Network	20	1000	No	-
10	neurogranin-CaM	CaM Pathway No. 14	Network	0	1000	No	-
11	neurogranin*	CaM Pathway No. 14	Network	0	1000	No	-
12	neurogranin	CaM Pathway No. 14	Network	10	1000	No	-
13	CaM-Ca3	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	0	1000	No	-
14	CaM-TR2-Ca2	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	0	1000	No	-
15	I1	PP1 Pathway No. 15	Network	1.8	1000	No	-
16	I1*	PP1 Pathway No. 15	Network	0.001	1000	No	-
17	PP1-I1*	PP1 Pathway No. 15	Network	0	1000	No	-
18	PP1-I1	PP1 Pathway No. 15	Network	0	1000	No	-
19	PKA-active	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	0	1000	No	-
20	PP2A	Shared_Object_ fig3_CaMKII Pathway No. 12	Network	0.12	1000	No	-

Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.